About GLP-1
GLP-1 (Glucagon-Like Peptide-1) is an incretin hormone peptide involved in glucose homeostasis and widely used in metabolic research. Supplied as a lyophilized powder for laboratory investigations into incretin signaling, insulin secretion pathway markers, and glucagon regulation mechanisms in controlled experimental models. Each batch undergoes analytical verification for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Effects of GLP-1 Receptor Agonists on Muscle Mass, Strength, and Quality in MASLD: A Systematic Review.
Recent research on GLP-1: Effects of GLP-1 Receptor Agonists on Muscle Mass, Strength, and Quality in MASLD: A Systematic Review.
Read Full Study on PubMedGLP-1 nutrition in the age of GLP-1s: When appetite shrinks but responsibility expands.
Recent research on GLP-1: GLP-1 nutrition in the age of GLP-1s: When appetite shrinks but responsibility expands.
Read Full Study on PubMedAdditional Studies
Evidence-based pharmacy actions for GLP-1 and GIP therapy during supply recovery.
Recent research on GLP-1: Evidence-based pharmacy actions for GLP-1 and GIP therapy during supply recovery.
Read on PubMedDivergent renal benefits of SGLT2 inhibitors and mineralocorticoid receptor antagonists in non-diabetic kidney disease.
Recent research on GLP-1: Divergent renal benefits of SGLT2 inhibitors and mineralocorticoid receptor antagonists in non-diabetic kidney disease.
Read on PubMedAuthors' Reply: SGLT2 Inhibitors vs GLP-1 Receptor Agonists Type 2 Diabetes, the Kidney Conundrum.
Recent research on GLP-1: Authors' Reply: SGLT2 Inhibitors vs GLP-1 Receptor Agonists Type 2 Diabetes, the Kidney Conundrum.
Read on PubMedEfficacy of GLP-1 Receptor agonists in treating Obstructive sleep apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomes.
Recent research on GLP-1: Efficacy of GLP-1 Receptor agonists in treating Obstructive sleep apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomes.
Read on PubMedGLP-1 receptor agonist-SGLT-2 inhibitor combination and risk of major adverse liver and cardiovascular outcomes in adults with MASLD and type 2 diabetes.
Recent research on GLP-1: GLP-1 receptor agonist-SGLT-2 inhibitor combination and risk of major adverse liver and cardiovascular outcomes in adults with MASLD and type 2 diabetes.
Read on PubMedComparative Use Human Factors Study of a Manual vs. A Partially Automated Pen Injector for GLP-1 Receptor Agonist Delivery.
Recent research on GLP-1: Comparative Use Human Factors Study of a Manual vs. A Partially Automated Pen Injector for GLP-1 Receptor Agonist Delivery.
Read on PubMedRelated Research
Purchase GLP-1 from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.